Latest News by Industry
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 9, 2022--
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, at 10:55 a.m. ET in New York, NY.
A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221109005349/en/
CONTACT: Investors
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.comMedia
Matthew Henson
917-930-7147
matthew.henson@sagerx.com
KEYWORD: NEW YORK MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: MENTAL HEALTH HEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY
SOURCE: Sage Therapeutics, Inc.
Copyright Business Wire 2022.
PUB: 11/09/2022 06:30 AM/DISC: 11/09/2022 06:32 AM
http://www.businesswire.com/news/home/20221109005349/en